BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
See today's BioWorld MedTech
Home
» SEMDA 2013: Leahey: med-tech firms' voices still matter despite difficulties
To read the full story,
subscribe
or
sign in
.
SEMDA 2013: Leahey: med-tech firms' voices still matter despite difficulties
Feb. 20, 2013
By
Omar Ford
ATLANTA — Some would say that in recent years the landscape for med-tech has been littered with difficulties and challenges often resulting in many devicemakers feeling as if their voice has been diminished.
Medical technology